Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Additive formula of medicinal and food homologous food for dispelling toxoplasma gondii and preparation method thereof

A technology of homology of medicine and food, Toxoplasma gondii, applied in food processing, pharmaceutical formulations, food ingredients containing natural extracts, etc., can solve the problems of anxiety and anxiety of patients and their families, wasting money of sick families, and misinterpreting doctors, etc., and achieve improvement. The effect of improving cell quality, enhancing human function, and improving cell condition

Inactive Publication Date: 2018-11-30
北京刚地源弓形虫病医学研究院
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the quality of the examination is not high, the quality of reagents and screening methods need to be standardized, and many clinicians are not familiar with the significance and correct judgment of serological examination results
False positive results and doctor’s misinterpretations caused by low-quality tests not only waste the money of patients, but also cause unnecessary anxiety and anxiety for patients and their families, and bring a lot of mental burden. Loss
The traditional anti-toxoplasma drugs are sulfadiazine and pyrimethamine, and now spiramycin, clindamycin, azithromycin and other drugs can also be used for treatment, but these drugs have certain toxic and side effects and require Follow the doctor's advice for treatment, which is not applicable in daily life, and cannot solve the infection of Toxoplasma gondii in most people

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0032] The raw materials of the present invention and their amounts are as follows:

[0033] Product name

Dosage

Percentage

Polygonatum

50

19%

Wolfberry

30

11%

Licorice

15

6%

honeysuckle

10

4%

Yam

50

19%

Sea buckthorn

20

7%

Hawthorn

50

19%

purslane

10

4%

Khumbu

8

3%

Angelica

10

4%

Hovenia dulcis

10

4%

[0034] The raw materials in this formula all meet the medical and food homology standards issued by the National Health and Family Planning Commission. The design of this formula was not designed according to the drug formula at the beginning. The purpose is to make it compatible with most foods on the market, and does not need to be eaten. Taboos, milk of young and old women can be consumed.

[0035] The processing method is as follows:

[0036] The processing method of the present invention is as follows:

[0037] 1. Raw material selection:

[0038] Polygonatum: Choose a finished product of Polygonatum with uniform size, sweet, waxy, and no jerky feeling. Sift out impurities an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an additive formula of medicinal and food homologous food for dispelling toxoplasma gondii. The additive formula comprises the following raw materials in percentage by weight:19% of rhizoma polygonati, 11% of fructus lycii, 6% of liquorice root, 4% of honeysuckle flower, 19% of Chinese yam rhizome, 7% of fructus hippophae, 19% of fructus crataegi, 4% of herba portulacae, 3% of kelp, 4% of radix angelicae, 4% of semen hoveniae. By eating food added with the additive formula of medicinal and food homologous food and using the habit of the toxoplasma gondii, the toxoplasma gondii is dispelled from cells through reducing the activity of the toxoplasma gondii, and the toxoplasma gondii is dispelled from human body in a way of discharging out of the human body through self metabolic function of the human body, therefore solving various problems in general population caused by infection of the toxoplasma gondii and meeting the actual application requirements.

Description

Technical field [0001] The invention relates to a medicinal and food homologous food additive formula for repelling Toxoplasma gondii and a preparation method thereof, and belongs to the technical field of medicinal food additives. Background technique [0002] Toxoplasma Gondii (Toxoplasma Gondii) is called three zombie worms in Chinese medicine. It is an intracellular parasite that flows with the blood and reaches various parts of the body, destroying the brain, heart, and fundus of the eyes, resulting in a decline in human immunity and various diseases. It is an obligate intracellular parasite, Coccidia, Eucoccidia, Isosporidae, Toxoplasma. Its existence has been confirmed by scholars and professional institutions at home and abroad. Toxoplasma gondii infections in humans and animals are widely distributed all over the world. The adult infection rate in British and American surveys is generally about 16-40%, and some reach 70%, while the adult infection rate in European and L...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23L33/105A23L33/10A61K36/8969A61P33/02
CPCA23V2002/00A61K36/03A61K36/185A61K36/232A61K36/355A61K36/484A61K36/72A61K36/734A61K36/815A61K36/8945A61K36/8969A61K2236/37A61K2236/53A23L33/10A23L33/105A61P33/02A23V2200/30A23V2250/202A23V2250/21A23V2300/14A23V2300/44A61K2300/00
Inventor 苗向光
Owner 北京刚地源弓形虫病医学研究院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products